D-Thyroxine
Code | Size | Price |
---|
TAR-T21383-1mL | 1 mL * 10 mM (in DMSO) | £111.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T21383-25mg | 25mg | £111.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
Dextrothyroxine could lower cholesterol and also increases hepatic lipase which in turn improves utilization of triglycerides, leading to improve apolipoprotein E cholesterol particles.
CAS:
51-49-0
Formula:
C15H11I4NO4
Molecular Weight:
776.87
Purity:
1
SMILES:
C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)C[C@H](C(=O)O)N
References
1. Schwartz ID, Bercu BB. Dextrothyroxine in the treatment of generalized thyroid hormone resistance in a boy homozygous for a defect in the T3 receptor. Thyroid. 1992 Spring;2(1):15-9. PubMed PMID: 1525565.
2. Krawczynska H, Wojcik-Musialek K, Illig R. 10 years of successful treatment with dextrothyroxine in a girl with TSH-induced hyperthyroidism. Horm Res. 1991;35(5):213-6. PubMed PMID: 1802825.
3. Hazenberg HJ, Muller CJ, Kerckhoffs HP, Erkelens DW. Dextrothyroxine induced hyperthyroidism in a patient with heterozygous familial hypercholesterolaemia. Neth J Med. 1987 Oct;31(3-4):117-21. PubMed PMID: 3683682.
4. Hankins JH, Heise CM, Cowan RJ. Iatrogenic hyperthyroidism secondary to dextrothyroxine administration. Clin Nucl Med. 1984 Jan;9(1):17-9. PubMed PMID: 6697613.